Department of Pharmacology and Regenerative Medicine, The University of Illinois at Chicago, College of Medicine, Chicago, United States
Anastasia Zhurikhina
Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University School of Medicine, Atlanta, United States
The David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, United States; Center for Precision Cancer Medicine, Massachusetts Institute of Technology, Cambridge, United States; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, United States
Vincent Huyot
Department of Pharmacology and Regenerative Medicine, The University of Illinois at Chicago, College of Medicine, Chicago, United States
Martin Brennan
Department of Pharmacology and Regenerative Medicine, The University of Illinois at Chicago, College of Medicine, Chicago, United States
The David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, United States; Center for Precision Cancer Medicine, Massachusetts Institute of Technology, Cambridge, United States; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, United States; Program in Computational and Systems Biology, Massachusetts Institute of Technology, Cambridge, United States
Jacob Matsche
Department of Pharmacology and Regenerative Medicine, The University of Illinois at Chicago, College of Medicine, Chicago, United States
Shahzeb Khan
Department of Pharmacology and Regenerative Medicine, The University of Illinois at Chicago, College of Medicine, Chicago, United States
Viswanathan Natarajan
Department of Pharmacology and Regenerative Medicine, The University of Illinois at Chicago, College of Medicine, Chicago, United States
Department of Pharmacology and Regenerative Medicine, The University of Illinois at Chicago, College of Medicine, Chicago, United States; University of Illinois Cancer Center, The University of Illinois at Chicago, Chicago, United States; Division of Cardiology, Department of Medicine, The University of Illinois, College of Medicine, Chicago, United States
Pradeep Kota
Marsico Lung Institute, Cystic Fibrosis Center and Department of Medicine, University of North Carolina, Chapel Hill, United States
The David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, United States; Center for Precision Cancer Medicine, Massachusetts Institute of Technology, Cambridge, United States; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, United States; Program in Computational and Systems Biology, Massachusetts Institute of Technology, Cambridge, United States
Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University School of Medicine, Atlanta, United States
Department of Pharmacology and Regenerative Medicine, The University of Illinois at Chicago, College of Medicine, Chicago, United States; University of Illinois Cancer Center, The University of Illinois at Chicago, Chicago, United States
Engineered allosteric regulation of protein activity provides significant advantages for the development of robust and broadly applicable tools. However, the application of allosteric switches in optogenetics has been scarce and suffers from critical limitations. Here, we report an optogenetic approach that utilizes an engineered Light-Regulated (LightR) allosteric switch module to achieve tight spatiotemporal control of enzymatic activity. Using the tyrosine kinase Src as a model, we demonstrate efficient regulation of the kinase and identify temporally distinct signaling responses ranging from seconds to minutes. LightR-Src off-kinetics can be tuned by modulating the LightR photoconversion cycle. A fast cycling variant enables the stimulation of transient pulses and local regulation of activity in a selected region of a cell. The design of the LightR module ensures broad applicability of the tool, as we demonstrate by achieving light-mediated regulation of Abl and bRaf kinases as well as Cre recombinase.